维普中文期刊产品整合服务
8篇 您的检索式:作者名="Scheltens T"
    题名 作者 年代 出处 被引量
1White matter lesion progression:A surrogate endpoint for trials in cerebral small-vessel disease显示文摘Schmidt R Scheltens P Erkinjuntti T 2004Neurology2004,63,:1
2Estimation of cardiovascular risk: a comparison between the Framingham and the SCORE model in people under 60 years of age显示文摘Scheltens T Verschuren WM Boshuizen HC 2008Eur J Cardiovasc Prev Rehabil2008,15,5:1
3white matter lesion progression:a surrogate endpoint for trials in cerebral small-vessel disease显示文摘8Schmidt R Scheltens P Erkinjuntti T 2004Neurology2004,63,:1
4White matter lesion progression:a surrogate endpoint for trials in cerebral small-vessel disease显示文摘Schmidt R Scheltens P Erkinjuntti T 0,,01:1
5White matter lesion progression: A surrogate endpoint for tri- als in cerebral smaU-vessd disease显示文摘SCHMJDT R SCHELTENS P H ERKINJUNTYI T 2004Neurology2004,63,:1
6How Useful Is the IQCODE for Discriminating between Alzheimer’s Disease, Mild Cognitive Impairment and Subjective Memory Complaints?显示文摘Sikkes Sietske A M Van Den Berg Mark T Knol Dirk L De Lange-de Klerk Elly S M Scheltens Philip Uitdehaag Bernard M J Klein Martin Pijnenburg Yolande A L 2010Dementia and Geriatric Cognitive Disorders2010,,:1
7Estimation of cardiovascular risk:a comparison between the Framingham and the SCORE model in people under 60 years of age显示文摘Scheltens T Verschuren WM Boshuizen HC 0,,05:1
8Estimation of cardiovascular risk: a compari- son between the Framingham and the SCORE model in people under 60 years of age 显示文摘SCHELTENS T VERSCHUREN W M M BOSHUIZEN H C 2008European Journal of Cardiovascular Prevention & Rehabilitation2008,15,5:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费